eUROGEN’s Coordinator is Prof. Christopher Chapple, Consultant Urological Surgeon at Sheffield Teaching Hospitals NHS Foundation Trust and Secretary General of the European Association of Urology (EAU).

Strategic Board

The Strategic Board for eUROGEN is chaired by the Coordinator and includes one representative from each healthcare provider, a representative from the patient advisory board, a representative from the EAU, and a representative of the European Commission.  Members of the Board may appoint a Deputy if they are not able to attend a Board meeting.  Decisions will be taken by consensus or a majority agreement of 80%. This Strategic Board will be responsible for discussing strategic issues relating to the development and expansion of the activities of the ERN, such as new applications from HCPs and Affiliated Partners and initiatives relating to guideline development, dissemination of information and training.

Operational Board

The Operational Board is comprised of the Coordinator, the Manager, the three workstream leaders, a representative of the EAU Guidelines Office, and a representative of the patient advisory group. An ex officio position will be available to a representative of the European Commission. Where added value can be achieved, other ERN networks will be invited to be represented. The Operational Board will report and make recommendations to the Strategic Board for our ERN. The Operational Board will meet at regular intervals using the IT platform, and as much as possible will develop standard operating procedures, initiate new education and (surgical) training activities and stimulate and initiate research developments within the fields of expertise and patients interest. Actions will be set for new specific guideline development. The workstream structure and patient and expertise input will be used to uniform approaches in all Member States. The Operational Board will meet more frequently (3 times a year) than the Strategic Board (once a year). Workstream leaders will hold meetings via the IT platform according to need, but at least 3 times a year.

Advisory Boards

Advisory Boards will deliver input from other fields of expertise as well as from the involved patient organisations. Evaluation and audit systems will be developed for quality control and improvement of the whole network and specific healthcare where needed.

Most importantly, when the ERN Clinical Patient Management System is operational, the ERN will also be delivering clinical services e.g.: European virtual multi-disciplinary team meetings which will provide diagnoses, recommendations for treatment or second opinions. The clinical governance for eUROGEN will operate a ‘direct lines of sight’ approach for the delivery of these clinical services.